Ontozry scores MHRA authorisation for focal-onset seizures
Drug approved to treat adult patients with epilepsy which has not been adequately controlled with at least two anti-epileptic therapies
Read More
Tag: Arvelle Therapeutics
Angelini Pharma acquires CNS specialist Arvelle Therapeutics
Key focus of the deal is focal-onset seizure treatment cenobamate
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
